Hygiene and health brands owner Reckitt reported a strong third-quarter performance, with core like-for-like revenue increasing by 6.7%, boosted by a return to growth in North America and Europe.

The Reckitt Group – which owns brands including Dettol, Strepsils, Gaviscon, Nurofen, Durex, and Harpic – posted a revenue increase of 4.2% to £3.6bn, with like-for-like sales going up by 7%.

Kris Licht, chief executive officer of Reckitt said: “We have delivered a strong third-quarter performance with LFL net revenue up 6.7% in Core Reckitt.

Subscribe to Grocery Gazette for free

Sign up here to get the latest grocery and food news each morning

“These results reflect sequential volume improvements and the strength of our Powerbrands. We returned to growth in Developed Markets against a challenging consumer landscape and continued to deliver outsized growth in Emerging Markets.

The firm’s financial report also showed its European net revenue increased by 0.8% on a like-for-like basis to £865m in the third quarter. However, volumes declined by 0.5%, which marked an improvement from the previous quarter’s decline of 1.9%.

The business maintained its financial guidance for the rest of the year, expecting a revenue growth of 4% for Core Reckitt brands and forecasts for overall group net revenue growth of between 3% and 4%.

Licht added: “With our sharpened operating structure, we are executing our plan and progressing our strategic objectives to be a world-class consumer health and hygiene company.

“We are pleased with our performance, and we are confident in delivering our full-year 2025 guidance.”